Home
Conditions
Paramyxoviridae Infections

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

NCT01065935

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Clinical Site Phoenix, Arizona, United States

Clinical Site Los Angeles, California, United States

Clinical Site Denver, Colorado, United States

Clinical Site Tampa, Florida, United States

View all 33 locations

View Trial Details

Completed

Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)

NCT00566527

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

NCT00658086

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Clinical Site San Diego, California, United States

Clinical Site San Francisco, California, United States

Clinical Site Denver, Colorado, United States

Clinical Site Gainesville, Florida, United States

View all 13 locations

View Trial Details

Completed

Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

NCT01906164

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Investigational Site Rennes, France

View Trial Details

Completed

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

NCT02231671

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Quotient Clinical Nottingham, United Kingdom

View Trial Details

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

NCT02692599

Conditions: Infections, Mononegavirales Infections, Mouth Diseases, +9 more
Locations: Dingxing County Center for Disease Control and Prevention Baoding, Hebei, China

View Trial Details

Completed

Safety Study of ProQuad® rHA in Infants (V221-037)

NCT00560755

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine

NCT02901990

Conditions: Body Temperature Changes, Fever, Infections, +14 more
Locations: wujin district CDC Changzhou, Jiangsu, China

lianshui county CDC Huaian, Jiangsu, China

ganyu district CDC Lianyungang, Jiangsu, China

gaogang district CDC Taizhou, Jiangsu, China

View Trial Details

Completed

Effect of Heliox on RSV Bronchiolitis

NCT03171142

Conditions: Acute Bronchiolitis, Infections, Mononegavirales Infections, +6 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

NCT01905215

Conditions: Infections, Infections, Respiratory Syncytial Virus, Mononegavirales Infections, +5 more
Locations: GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Brampton, Ontario, Canada

GSK Investigational Site Toronto, Ontario, Canada

View Trial Details

Paramyxoviridae Infections

Paramyxoviridae Infections trial results

Related conditions